Comparison of protection by L-ascorbic acid, L-cysteine, and adrenergic-blocking agents against acetaldehyde, acrolein, and formaldehyde toxicity: implications in smoking.
D000079:Acetaldehyde / Q000633:toxicity*; D000171:Acrolein / Q000633:toxicity*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D000447:Aldehydes / Q000633:toxicity*; D000758:Anesthesia; D000818:Animals; D001205:Ascorbic Acid / Q000627:therapeutic use*; D003545:Cysteine / Q000627:therapeutic use*; D005557:Formaldehyde / Q000633:toxicity*; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010146:Pain / Q000209:etiology; D051381:Rats; D012127:Respiratory Distress Syndrome, Newborn / Q000401:mortality; D012907:Smoking / Q000188:drug therapy; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D000447:Aldehydes; D005557:Formaldehyde; D000171:Acrolein; D000079:Acetaldehyde; D003545:Cysteine; D001205:Ascorbic Acid